| Descriptive cohort (n = 103) | Correlative cohort (n = 66) | Anti-EGFR treated (n = 39) | |||
---|---|---|---|---|---|---|
 | n | % | n | % | n | % |
EGFR mutational status | Â | Â | Â | Â | Â | Â |
  Wild-type | 72 | 70 | 47 | 71 | 24 | 62 |
  Mutant | 31 | 30 | 19 | 29 | 15 | 38 |
Sites of EGFR mutation | Â | Â | Â | Â | Â | Â |
  Exon 19 deletion | 24 | 77* | 14 | 74* | 12 | 80* |
E746_A750del | 19 | 62* | 10 | 54* | 8 | 52* |
E746_R748del | 1 | 3* | 1 | 5* | - | - |
E746_E749 > Y | 1 | 3* | 1 | 5* | 1 | 7* |
L747_A750>P | 1 | 3* | 1 | 5* | 1 | 7* |
L747_T751del | 1 | 3* | 1 | 5* | 1 | 7* |
S751_I759del | 1 | 3* | - | - | 1 | 7* |
  Exon 20 mutation | 3 | 10* | 2 | 10* | - | - |
G796D | 2 | 7* | 1 | 5* | - | - |
A767_V769dup | 1 | 3* | 1 | 5* | - | - |
  Exon 21 mutation | 4 | 13* | 3 | 16* | 3 | 20* |
L858R | 4 | 13* | 3 | 16* | 3 | 20* |
K-Ras mutational status | Â | Â | Â | Â | Â | Â |
  Wild-type | 76 | 73 | 46 | 70 | 30 | 77 |
  Mutant | 13 | 13 | 9 | 14 | 4 | 10 |
  Not evaluable | 14 | 14 | 11 | 16 | 5 | 13 |
Sites of K-Ras mutation | Â | Â | Â | Â | Â | Â |
  Codon 12 mutation | 10 | 77* | 7 | 78* | 4 | 100* |
G12C | 6 | 46* | 4 | 44* | 3 | 75* |
G12D | 1 | 8* | - | - | - | - |
G12V | 3 | 23* | 3 | 34* | 1 | 25* |
  Codon 13 mutation | 3 | 23* | 2 | 22* | - | - |
G13D | 3 | 23* | 2 | 22* | - | - |